Recent Articles
South32 (ASX:S32) Beats Profit Estimates by 12.5% and Hikes Dividend- Is It Time to Buy?
South32 Profit Surprise Meets High…
Origin Energy (ASX:ORG) Surges Despite 45% Profit Drop- Is the Market Right to Be Bullish?
Origin Energy Surges on Upgraded…
Syrah Resources (ASX:SYR) Climbs 6% as US Graphite Tariff Case Advances- A Speculative Buy for Patient Investors?
Syrah Resources Surges on Tariff…
What is the VIX and what are the factors that cause it to violently surge and go into tailspins?
You may hear the occasional…
Temple & Webster (ASX:TPW) Crashes 33% Despite 20% Revenue Growth- Time to Buy the Dip or Stay Away?
Temple & Webster Slumps on…
New Frontier Minerals (ASX:NFM) The Smart Part of This Deal Is Metallium (ASX:MTM)
Canada Exposure, Metallium Processing, One…
Pro Medicus (ASX:PME) Down 16% on a Great Result, Here’s Why
A Premium Multiple Leaves No…
AMP (ASX:AMP) Statutory Profit Sank, Underlying Profit Jumped, So Why Did It Fall?
The Market Saw $133m, Not…
Kelly Partners (ASX:KPG): A Home-Grown Accounting Firm With Strong Growth And Expanding Abroad, So Why Is It Falling?
Kelly Partners (ASX:KPG) has endured…
Private equity listings on the ASX that came and went: Here are 9 of the most recent!
Private equity listings on the…
Centuria Industrial REIT (ASX:CIP) Upgrades Earnings- Is It a Buy at 18% Below Asset Value?
Centuria Industrial Trades at a…
A Blood Test Instead of a Colonoscopy? Rhythm Biosciences (ASX:RHY) Takes Its First Commercial Step
Rhythm Biosciences Starts ColoSTAT Pilot,…
Evolution Mining (ASX:EVN) Surges 9% on Record $767M Profit- So Why Do Most Analysts Still Say Sell?
Evolution Mining Hits Record Profit,…
Commonwealth Bank (ASX:CBA) Reports 6% Profit Growth and Raises Dividend- Buy, Hold, or Take Profits?
Commonwealth Bank Beats Forecasts, But…
Great Dirt Resources (ASX:GR8) Up 130% on a $1.45m Cornerstoned Raise
Placement Locked In, Sentiment Explodes…
The Shift Toward Digital Currencies in the Australian Casino Sector
The Australian gaming industry is…
CSL Releases 1H26 Results Following CEO Exit Shock And Has More Than Halved in 2 Years! What’s Real vs Noise?
CSL Releases 1H26 Results:A Volatile…
CSL CEO Paul McKenzie has departed, now what for the fallen biotech giant?
In a bombshell 4pm announcement,…
Find Us in
Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.
Sector Analysis
The Best Mining Stocks
Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.
The Best Tech Stocks
Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.
The Best Uranium Stocks
Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.
The Best Healthcare Stocks
There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.
The Best Mining Stocks
The Best Tech Stocks
The Best Uranium Stocks
Share Type Analysis
The Best ASX Stocks Right Now
The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now.
The Best ASX Stocks Right Now
The Top Penny Stocks
Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.
The Top Penny Stocks
The Top Dividend Stocks
Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.
The Top Dividend Stocks
Top ASX Index Funds
Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.
Top ASX Index Funds
The Top Blue Chip Stocks
Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.
The Top Blue Chip Stocks
Top ASX Growth Stocks for Investing
Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.
Top ASX Growth Stocks for Investing
Webinars and Interviews
DorsaVi (ASX:DVL) unveiled its ambitious 22nm ReRAM strategy: Interview with Group CEO Mathew Regan
DorsaVi (ASX:DVL) is switching into high gear We spoke to DorsaVi’s Group CEO, Mat Regan, about…
Unicycive Therapeutics (Nasdaq:UNCY) has big plans for its lead candidate OLC
Unicycive Therapeutics (Nasdaq:UNCY) Unicycive Therapeutics is a clinical-stage biotech company based in Los Altos, CA. The…
Weebit Nano signs license deal with Texas Instruments: Interview with CEO Coby Hanoch
Weebit Nano bags an analog elephant We spoke with CEO Coby Hanoch about the license deal…
Chimeric Therapeutics (ASX:CHM) is headed for the CAR-T ‘Big Time’
Chimeric Therapeutics (ASX:CHM) We spoke to Dr Rebecca McQualter, CEO of Chimeric Therapeutics (ASX:CHM), about the…
Investment Glossary
What Is a Small Cap Company? A Complete Guide for Investors
Overview of Small Cap Companies…
What is the All Ordinaries Index and How Does It Work?
The All Ordinaries Index, also…
What is Commodity? Understanding Commodity Trading
Introduction to Commodities Commodities are…
Overview of Securities in the Australian Financial Market
What is a security? Security refers…
What Is an IPO? Understanding Initial Public Offerings
What is IPO? An Initial Public…
The Team Behind Stocks Down Under
Stuart Roberts
Co-Founder
Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research
Marc Kennis
Co-Founder
Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,
The Team Behind Stocks Down Under
STUART ROBERTSStuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.
MARC KENNISMarc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.
PETER KILBYPete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.
Get in touch
contact@stocksdownunder.com
Follow us on